Shield Therapeutics Plc (STX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2015 | 12-2014 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 1,074 | 742 |
| Other current assets | 142 | 79 |
| TOTAL | $3,452 | $865 |
| Non-Current Assets | ||
| PPE Net | 25 | 19 |
| Intangibles | 760 | 679 |
| TOTAL | $785 | $697 |
| Total Assets | $4,237 | $1,563 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 0 | 12,853 |
| Accounts payable and accrued liabilities | 1,797 | 652 |
| Other current liabilities | 108 | 78 |
| TOTAL | $5,296 | $14,011 |
| Non-Current Liabilities | ||
| Long Term Debt | 0 | 307 |
| Other Non-Current Liabilities | 26,560 | 12,986 |
| TOTAL | $26,560 | $16,010 |
| Total Liabilities | $31,857 | $30,021 |
| Shareholders' Equity | ||
| Common Shares | 1,022 | 568 |
| Retained earnings | -70,597 | -35,808 |
| Other shareholders' equity | 41,955 | 339 |
| TOTAL | $-27,620 | $-31,176 |
| Total Liabilities And Equity | $4,237 | $-1,155 |